BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38877473)

  • 21. Marked Response to Nivolumab by a Patient With SMARCA4-Deficient Undifferentiated Urothelial Carcinoma Showing High PD-L1 Expression: A Case Report.
    Arihara Y; Omori G; Kobayashi K; Sugita S; Murase K; Kubo T; Idogawa M; Hasegawa T; Takada K
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2127. PubMed ID: 38923369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
    Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
    Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.
    Horton RK; Ahadi M; Gill AJ; Said S; Chen ZE; Bakhshwin A; Nichols M; Goldblum JR; Graham RP
    Am J Surg Pathol; 2021 Mar; 45(3):414-420. PubMed ID: 33027072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case Report: Gastrointestinal neuroendocrine carcinoma with SMARCA4 deficiency: a clinicopathological report of two rare cases.
    Zhou P; Fu Y; Wang W
    Front Oncol; 2023; 13():1290717. PubMed ID: 38090508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
    Tessier-Cloutier B; Coatham M; Carey M; Nelson GS; Hamilton S; Lum A; Soslow RA; Stewart CJ; Postovit LM; Köbel M; Lee CH
    J Pathol Clin Res; 2021 Mar; 7(2):144-153. PubMed ID: 33125840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
    Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
    [No Abstract]   [Full Text] [Related]  

  • 29. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses.
    Perret R; Chalabreysse L; Watson S; Serre I; Garcia S; Forest F; Yvorel V; Pissaloux D; Thomas de Montpreville V; Masliah-Planchon J; Lantuejoul S; Brevet M; Blay JY; Coindre JM; Tirode F; Le Loarer F
    Am J Surg Pathol; 2019 Apr; 43(4):455-465. PubMed ID: 30451731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of SMARCA4 (BRG1)-deficient carcinomas following a malignant pleural effusion specimen confounded by reduced claudin-4 expression.
    Early CA; Wangsiricharoen S; Jones RM; VandenBussche CJ
    J Am Soc Cytopathol; 2021; 10(2):197-207. PubMed ID: 32893180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytopathological Features of
    Takeda M; Tani Y; Saijo N; Shimizu S; Taniguchi Y; Otsuka K; Nakao K; Tamiya A; Okishio K; Atagi S; Ohbayashi C; Kasai T
    Int J Surg Pathol; 2020 Feb; 28(1):109-114. PubMed ID: 31448657
    [No Abstract]   [Full Text] [Related]  

  • 33. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
    Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
    Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.
    Chang B; Sheng W; Wang L; Zhu X; Tan C; Ni S; Weng W; Huang D; Wang J
    Am J Surg Pathol; 2022 Jul; 46(7):889-906. PubMed ID: 34812766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review.
    Duan H; Gao W; Wang L; Cao F; Teng L
    Diagn Pathol; 2021 Apr; 16(1):30. PubMed ID: 33836796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]   [Full Text] [Related]  

  • 37. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
    Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
    Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
    Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
    Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of BRG1 (
    Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
    Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.